-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

622. Lymphomas: Translational–Non-Genetic: Poster III

Symposia: Lymphomas: Translational–Non-Genetic Program: Oral and Poster Abstracts
Type: Poster
Monday, December 12, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Daisuke Ikeda1*, Toshiki Terao, MD2*, Ami Fukumoto, MD3*, Ayumi Kuzume, MD4*, Yuya Kamura, MD5*, Rikako Tabata, MD4*, Takafumi Tsushima, MD5*, Daisuke Miura, MD2*, Kentaro Narita, MD6*, Masami Takeuchi, MD5*, Takeshi Yamashita, MD7*, Hiroyuki Takamatsu, MD, PhD8 and Kosei Matsue, MD, PhD9

1Division of Hematology/Oncology, Kameda Medical Center, Kamogawa-Shi, CHI, Japan
2Division of Hematology/Oncology, Department of Medicine, Kameda Medical Center, Kamogawa, Japan
3Division of Hematology/Oncology, Kameda Medical Center, Chiba, JPN
4Division of Hematology/Oncology, Kameda Medical Centor, Kamogawa, Japan
5Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Japan
6Division of Hematology/Oncology, Department of Medicine, Kameda Medical Center, Kamogawa, CHI, Japan
7Division of Internal Medicine, Keiju Kanazawa Hospital, Kanazawa, Japan
8Department of Hematology, Kanazawa University, Kanazawa, Japan
9Department of Hematology/Oncology, Kameda Medical Center, Kamogawa, Japan

Cèlia Dobaño-López, MSc1,2*, Juan G Valero, PhD1,2*, Ferran Araujo-Ayala1,2*, Ferran Nadeu, PhD1,2*, Fabien Gava, PhD3*, Carla Faria, PhD3*, Marine Norlund, PhD4*, Renaud Morin, PhD4*, Pascale Bernes-Lasserre4*, Neus Serrat, MD, PhD2*, Heribert Playa-Albinyana, MSc1,2*, Andrea Rivero, MD5*, Pablo Mozas, MD, PhD5*, Elías Campo, PhD MD1,2,6,7, Jean-Michel Lagarde, PhD4*, Armando López-Guillermo, MD, PhD1,2,5,7*, Dolors Colomer, PhD1,2,6,7*, Christine Bezombes, PhD3* and Patricia Pérez-Galán, PhD1,2*

1Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain
2Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
3Centre de Recherches en Cancérologie de Toulouse, INSERM, Toulouse, France
4IMACTIV-3D, Toulouse, France
5Hematology Department, Hospital Clínic of Barcelona, Barcelona, Spain
6Hematopathology Section, Pathology Department, Hospital Clinic, Barcelona, Spain
7University of Barcelona, Barcelona, Spain

Huang-Chang Liang*, Richa Kapoor, PhD*, Ozlem Onder, PhD*, Kevin Dennis*, Megan S. Lim, MD, PhD and Kojo S. J. Elenitoba-Johnson, MD

Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA

PK Epling-Burnette, PharmD, PhD1*, Durga B Dandamudi, PhD1*, Iwona M Konieczna, PhD1*, Kelly M Calabrese1*, Monica Wielgos-Bonvallet, PhD2*, Christiaan Kweekel, MSc3*, Elke Gresnigt - van den Heuvel3*, Apurvasena Parikh, PhD4*, Tommy Li, PhD5*, Christopher W Chiu, PhD5*, Adam Chervin, PhD1*, Edward B Reilly, PhD1* and Edith Szafer-Glusman, PhD1*

1AbbVie Inc, North Chicago, IL
2Translational Research and Precision Medicine Operations, Genmab, Princeton, NJ
3Genmab, Utrecht, Netherlands
4AbbVie, South San Francisco, CA
5Genmab, Princeton, NJ

Beatriz Wills, MD1, Nivetha Ganesan, MPH2*, Gunjan L. Shah, MD3*, Phillip Wong, PhD4*, Kimon V. Argyropoulos, MD2*, Filiz Sen, MD5*, Ahmet Dogan, MD, PhD6, David J. Straus, MD2, Ariela Noy, MD2, Anita Kumar, MD2, Heiko Schoder, MD, MBA7*, Laure Michaud, MD7*, Maria Lia Palomba2, Lorenzo Falchi, MD8, Oscar B Lahoud, MD9, Paul A. Hamlin, MD2, Joachim Yahalom, MD10, William T. Johnson, DO2, Andrew D. Zelenetz, MD, PhD2, Andrew M. Intlekofer, MD, DPhil2, Colette Owens, MD2, Connie Lee Batlevi, MD, PhD11, Audrey Hamilton, MD2*, Philip C Caron, MD, PhD2, Steven M. Horwitz, MD2, Natasha Galasso, MSW2*, Helen Hancock, ANP2*, Theresa Davey, MMSc, PA-C12*, Alayna Santarosa, MPH12*, Leslie Perez, RN12*, Charisse Capadona, MS4*, Brittney Munayirji4*, Matthew J. Matasar, MD, MS13, Georgios Pongas, MD14, Ellie Casper, MS4*, Gilles Salles, MD, PhD2, Craig H. Moskowitz, MD14, Santosha Vardhana, MD, PhD2 and Alison J. Moskowitz, MD2

1Memorial Sloan Kettering Cancer Center, New York
2Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
3Department of Medicine, Adult Bone Marrow Transplant Service, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY
4Memorial Sloan Kettering Cancer Center, NYC
5Hematopathology Service, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
6Department of Pathology and Laboratory Medicine, Hematopathology Service, Memorial Sloan Kettering Cancer Center, New York, NY
7Department of Radiology, Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY
8Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
9Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
10Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
11Lymphoma Service, Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, NEW YORK, NY
12Memorial Sloan Kettering Cancer Center, New York, NY
13215 West 90th St, 14E, Memorial Sloan Kettering Cancer Center, New York, NY
14Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL

Ying Yu1*, Wenjie Xiong2*, Zanzan Wang3*, Yuting Yan2*, Jiawen Chen2*, Yanshan Huang2*, Xinxin Cao4*, Zhongxing Jiang5*, Huihan Wang6*, Zhen Cai, PhD, MD7*, Juan Du8*, Chunyan Sun, MD9*, Ting Niu10, Guangzhong Yang11*, Hua Xue12*, Bingzong Li, MD, PhD13, Honghui Huang14*, Zhenling Li15*, Qinhua Liu16*, Fei Li17*, Ou Bai, MD/PhD18*, Min Mao19*, Rong Fu, MD20*, Ling Wang21*, Chunrui Li, MD, PhD22, Xiaoxia Chu23*, Lihong Liu24*, Yujun Dong25*, Luqun Wang26*, Jun Luo27*, Yongqiang Wei28*, Lugui Qiu2, Jian Li, MD29 and ShuHua Yi2*

1State Key Laboratory of Experimental Hematology, National Clinical Research Cent, Tianjin, China
2State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, Tianjin, China
3Department of Hematology, Ningbo First Hospital, Zhejiang, China
4Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
5The First Affiliated Hospital of Zhengzhou University, Henan, China
6Shengjing Hospital of China Medical University, Liaoning, China
7Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
8Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, The Second Military Medical University, Shanghai, China
9Union Hospital,Tongji Medical College,Huazhong University of Science and Technology, Wuhan, China
10West China Hospital of Sichuan University, Chengdu, Sichuan, China
11Department of Hematology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China
12The Second Hospital of Hebei Medical University, Hebei, China
13Department of Hematology, The second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
14Department of Hematology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
15Department of Hematology, China-Japan Friendship Hospital, Beijing, China
16Department of Hematology, The First Affiliated Hospital of Anhui Medical University, Anhui, China
17The First Affiliated Hospital of Nanchang University, Nanchang, China
18Department of Hematology, The First Hospital of Jilin University, Changchun, China
19Department of Hematology, Xinjiang Uiger Municipal People’s Hospital, Xinjiang, China
20Department of Hematology, Tianjin Medical University General Hospital, Tianjin, China
21Qingdao Central Hospital, Shandong, China
22Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
23The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Shandong, China
24Department of Hematology, The Fourth Hospital of Hebei Medical University, Hebei, China
25Department of Hematology, Peking University First Hospital, Beijing, China
26Department of Hematology, Qilu Hospital of Shandong University, Shandong, Shandong, China
27Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Guangxi, China
28Department of Hematology, Nanfang Hospital, Southern Medical University, Guangdong, China
29Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Alexander Biedermann1*, Doris Mangelberger-Eberl2*, Dimitrios Mougiakakos, MD3, Maike Büttner-Herold4*, Cindy Flamann5*, Christian Kellner6*, Sarah Altmeyer7*, Jörg Bittenbring8*, Christian Augsberger2*, Maria Patra-Kneuer, Ph.D.2*, Karin Landgraf2*, Kristina Ilieva-Babinski2*, Stefan Haskamp1*, Fabian Beier, MD9*, Simon Voelkl, PhD10*, Christian Pallasch11*, Benedikt Jacobs, MD12*, Stefan Steidl, Ph.D.2*, Christina Heitmüller, Ph.D.2*, Andreas Mackensen, MD13* and Heiko Bruns, PhD14*

1University Hospital Erlangen, Erlangen, Germany
2MorphoSys AG, Planegg, Germany
3Otto von Guericke University Magdeburg, Magdeburg, Germany
4Department of Nephropathology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
5Dept. of Internal Medicine 5 – Hematology/Oncology, University of Erlangen, Erlangen, Germany
6Department of Transfusion Medicine, Cell Therapeutics and Hemostaseology, University Hospital, LMU Munich, Munich, Germany
7Saarland University Hospital, Homburg, DEU
8Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Medical School, University of Saarland, Homburg, Germany
9Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, NRW, Germany
10Department of Internal Medicine 5 - Hematology/Oncology, University Hospital of Erlangen, Erlangen, Germany
11University Hospital of Cologne, Cologne, Germany
12Department of Hematology and Oncology, University Hospital Erlangen, Erlangen, Germany
13Dept. of Internal Medicine 5 - Hematology/Oncology, University Hospital of Erlangen, Erlangen, Germany
14Dept. of Internal Medicine 5 - Hematology/Oncology, University Hospital Erlangen, Erlangen, Germany

Marina Gerousi1*, Anastasia Iatrou1,2*, Antonios Mingos1,2*, Nikolaos Pechlivanis1,3*, Stavroula Ntoufa1*, Maria Gounari1*, Nikos Papakonstantinou1*, Georgios Karakatsoulis1,4*, Eleni Kotroni1*, Ioannis Sarrigeorgiou5*, Zadie Davis6*, Peggy Lymberi5*, David Oscier6, Ioanna Sakellari7*, Alexandra Traverse-Glehen8*, Niki Stavroyianni9*, Fotis Psomopoulos1*, Marta Muzio10*, Paolo Ghia, MD, PhD11, Anastasia Chatzidimitriou1,12* and Kostas Stamatopoulos, MD1,12

1Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece
2Department of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupolis, Greece
3Department of Genetics, Development and Molecular Biology, Faculty of Biology, Aristotle University of Thessaloniki, Thessaloniki, Greece
4Department of Mathematics, School of Sciences, University of Ioannina, Ioannina, Greece
5Immunology Laboratory, Immunology Department, Hellenic Pasteur Institute, Athens, Greece
6Royal Bournemouth Hospital, Bournemouth, United Kingdom
7Hematology Department and HCT Unit, George Papanikolaou General Hospital, Thessaloniki, Greece
8Department of Pathology, Centre Hospitalier Lyon Sud and Université Claude Bernard Lyon-1, Pierre- Bénite, France
9Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece
10Cell Signaling Unit, Division of Experimental Oncology, San Raffaele Hospital Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy
11Università Vita-Salute San Raffaele and Istituto di Ricovero e Cura a Carattere Scientifico Ospedale San Raffaele, Milan, Italy
12Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden

Harpreet Mandhair, MSc1,2*, Ramin Radpour, PhD1,2*, Andrew Davies3*, Mario P. Tschan, PhD4 and Urban Novak1,2*

1Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
2University of Bern, Department of BioMedical Research, Bern, Switzerland
3Southampton Cancer Research UK (CRUK) Centre/CRUK Experimental Cancer Medicines Centre UK/CRUK Southampton Clinical Trials Unit, University of Southampton, Southampton, United Kingdom
4Division of Experimental Pathology, Institute of Pathology, University of Bern, Bern, Switzerland

Vera de Jonge1*, Carolien Duetz, MD2*, Wassilis S.C. Bruins, MD, MSc3*, Erik D. van Werkhoven, MSc4*, Marcel Nijland, MD, PhD5*, Marjolein W.M. Van Der Poel6, Koen de Heer, MD, PhD7*, Clara P.W. Klerk, MD8*, Yorick Sandberg, MD9*, Rob Fijnheer10*, Pim Mutseaers, MD11*, Djamila E. Issa, MD, PhD12*, Lara H. Böhmer, MD13*, Roel J.W. Van Kampen, MD, PhD14, Otto J. Visser, MD15, Daphne de Jong, MD, PhD16*, Josée M. Zijlstra, MD PhD1, Tuna Mutis, MD, PhD17* and Martine E.D. Chamuleau, MD, PhD1

1Department of Hematology, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, Netherlands
2Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, location Vrije Universiteit Amsterdam, Amsterdam, NV, Netherlands
3Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, Netherlands
4Hovon data center, department of Hematology, Erasmus MC Cancer institute, Rotterdam, Netherlands
5Department of Hematology, University Medical Center Groningen and University of Groningen, Groningen, Netherlands
6Department of Hematology, Maastricht University Medical Center, Maastricht, Netherlands
7Department of Hematology, Amsterdam UMC, Amsterdam, Netherlands
8Dijklanderziekenhuis, Hoorn, Netherlands
9Department of Internal Medicine, Maasstad Hospital, Rotterdam, Netherlands
10Meander Medical Center, Department of Internal Medicine, Amersfoort, Netherlands
11Department of Hematology, Erasmus MC Cancer Center, Rotterdam, Netherlands
12Department of Hematology, Jeroen Bosch Hospital, Den Bosch, Netherlands
13Department of Hematology, Haga Teaching Hospital, The Hague, Netherlands
14Zuyderland Medical Center, Sittard-Geleen, NLD
15Department of Hematology, Isala Hospital, Zwolle, Netherlands
16Department of Pathology, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, Netherlands
17Cancer Biology and Immunology, Cancer Center Amsterdam, Amsterdam, Netherlands

Charline Fuseau, MD1,2*, Mathieu Baldacini, MD2*, Alina Nicolae, MD-PHD1,3*, Laurent Miguet, PhD1,4*, Laurent Mauvieux, MD, PhD1,4, Laurent Vallat, MD, PhD1,4*, Claire Domon-Dell, PhD1*, Manuela Tavian, PhD1*, Jean-Noel Freund, PhD1*, Sarah Cianferani, PhD5,6*, Christine Schaeffer-Reiss, PhD5,6*, Luc-Matthieu Fornecker, MD, PhD1,2* and Delphine C. M. Rolland, PharmD1,4

1Interface de Recherche Fondamentale et Appliquée en Cancérologie (IRFAC), INSERM UMR-1113, Université de Strasbourg, Strasbourg, France
2Institut de Cancérologie Strasbourg Europe, Strasbourg, France
3Département de pathologie, Hôpitaux Universitaire de Strasbourg, Strasbourg, France
4Laboratoire d’hématologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
5Laboratoire de Spectrométrie de Masse BioOrganique, Institut Pluridisciplinaire Hubert Curien (IPHC), CNRS UMR-7178, Université de Strasbourg, Strasbourg, France
6Infrastructure Nationale de Protéomique ProFi – FR2048 CNRS, Strasbourg, France

Xiaomin Chen1,2*, Tiange Lu1,2*, Yiqing Cai1,2*, Mengfei Ding1*, Zhuoya Yu1*, Xiangxiang Zhou, PhD2* and Xin Wang1,2

1Department of Hematology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, China
2Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China

Gensuke Takayama, PhD1*, Yoshiyuki Hizukuri, Ph.D.2*, Tomoyuki Fujioka, Ph.D.2*, Kazuyuki Hashimoto, Ph.D.2*, Kazumi Ito, D.V.M., Ph.D.2*, Hironori Yamada, MSc3*, Makoto Yamagishi, PhD4*, Makoto Nakashima, Ph.D.4*, Yutaka Suzuki, Ph.D.5*, Yasuhito Nannya, M.D., Ph.D.6, Kaoru Uchimaru, M.D., Ph.D.4,6* and Shinji Tsutsumi, Ph.D.2*

1Translational Science I, Daiichi Sankyo Co., Ltd., Shinagawa-Ku, Japan
2Translational Science I, Daiichi Sankyo Co., Ltd., Tokyo, Japan
3Clinical Development Department II, Daiichi Sankyo Co., Ltd., Tokyo, Japan
4Laboratory of Tumor Cell Biology, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan
5Laboratory of Systems Genomics, Department of Computational Biology and Medical Sciences, The University of Tokyo, Tokyo, Japan
6Department of Hematology/Oncology, IMSUT Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan

Jerzy Dyczkowski, PhD1*, Alex F. Herrera, MD2, Carmelo Carlo-Stella, MD, PhD3, Pier Luigi Zinzani, MD, PhD4, Marie Toukam, PhD5*, Hans G. Cruz, PhD1, Karin Havenith, PhD6*, Joseph Boni, PhD5*, Jens Wuerthner, MD, PhD1 and Serafino Pantano, PhD1*

1ADC Therapeutics SA, Épalinges, Switzerland
2Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, CA
3Department of Oncology and Hematology, Humanitas University and IRCCS Humanitas Research Hospital, Milan, Italy
4Institute of Hematology “Seràgnoli” University of Bologna, Bologna, Italy
5ADC Therapeutics America, Inc., Murray Hill, NJ
6ADC Therapeutics (UK) Ltd, London, United Kingdom

Ava J Boutilier1*, Anna D Metzler1*, Cameron E Banks2*, Sherine F Elsawa, PhD3, Stephan Josef Matissek3* and Katja Koeppen4*

1Molecular, Cellular, and Biomedical Sciences, University of New Hampshire, Durham, NH
2University of New Hampshire - Molecular, Cellular, and Biomedical Sciences, Durham, NH
3Molecular, Cellular and Biomedical Sciences, University of New Hampshire, Durham, NH
4Dartmouth College, Hanover

Richa Kapoor, PhD1*, Kaiyu Ma, PhD2*, Faith Key1*, Huang-Chang Liang3*, Xiao Zhang2*, Megan S. Lim, MD, PhD2 and Kojo S. J. Elenitoba-Johnson, MD2

1University of Pennsylvania, PHILADELPHIA, PA
2Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
3University of Pennsylvania, Philadelphia, PA

Maria Carmela Vegliante, PhD1*, Grazia Gargano, MSc1*, Flavia Esposito, PhD2*, Giuseppina Opinto, PhD1*, Gian Maria Zaccaria, PhD1*, Susanna Anita Pappagallo1*, Paolo Mondelli, MSc1*, Giacomo Loseto, MD1*, Anna Scattone, MD3*, Elena Sabattini, MD4*, Claudio Agostinelli, MD4*, Valentina Tabanelli, PhD5*, Luca Nassi, MD6*, Attilio Guarini, MD1*, Stefano A Pileri, MD5 and Sabino Ciavarella, PhD1*

1Hematology and Cell Therapy Unit, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy
2Department of Mathematics, University of Bari Aldo Moro, Bari, Italy
3Pathology Department, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy
4Haematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna and Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy
5Division of Diagnostic Haematopathology, IEO Istituto Europeo di Oncologia IRCCS, Milano, Italy
6Department of Hematology, Careggi Hospital and University of Florence, Florence, Italy

Hyokyoung G Hong, PhD1*, Mateus H Gouveia2*, Martin Ogwang3*, Patrick Kerchan4*, Steven Reynolds5*, Constance N Tenge6*, Pamela A Were7*, Robert T Kuremu6*, Walter N Wekesa6*, Nestory Masalu8*, Esther Kawira9*, Tobias Kinyera10*, Xunde Wang, PhD11*, Jiefu Zhou12*, Isaac Otim13*, Ismail D Legason13*, Hadijah Nabalende10*, Herry Dhudha9*, Mediatrix Mumia7*, Francine G Baker14*, Temi Okusolubo11*, Leona W Ayers15*, Kishor Bhatia, PhD16*, James J Goedert14*, Joshua G Woo14*, Nathan Cole17*, Wen Luo17,18*, Belynda Hicks19,20*, Adebowale A Adeyemo21*, Ludmila Prokunina-Olsson, PhD22*, Daniel N. Shriner, PhD23*, Charles N Rotimi21*, George Chagaluka24*, W Thomas Johnston25*, Nora Mutalima25*, Eric Borgstein24*, George N Liomba24*, Steve Kamiza24*, Nyengo Mkandawire24*, Collins Mitambo26*, Collins Mitambo26*, Elizabeth Molyneux27*, Robert Newton28*, Michelle Manning17*, Joseph F Fraumeni Jr.14*, Ruth M Pfeiffer14*, Amy Hutchinson29*, Meredith Yeager, PhD29*, Swee Lay Thein, DSc, FRCP, FRCPath, MBBS, MRCPath, MRCP30, Stephen J. Chanock, MD31* and Sam M. Mbulaiteye, MBBChir, MPhil32*

1Division of Cancer Epidemiology & Genetics, National Cancer Institute, Rockville, MD
2National Institutes of Health, Bethesda, MD
3EMBLEM study, ST. MARY'S HOSPITAL LACOR, Gulu, UGA
4African Field Epidemiology Network, Kampala, Uganda
5NIAID/NIH, Dulles, VA
6Moi University College of Health Sciences, Eldoret, Kenya
7Academic Model Providing Access To Healthcare (AMPATH), Eldoret, Kenya
8Bugando Medical Center, Mwanza, Tanzania, United Republic of
9Shirati Health, Education, and Development Foundation, Shirati, Tanzania, United Republic of
10ST. MARY'S HOSPITAL LACOR, Gulu, UGA
11Sickle Cell Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
12Department of Statistics and Probability, Michigan State University, Michigan, MI
13St. Mary’s Hospital, Lacor, Gulu, Uganda
14National Cancer Institute, Rockville, MD
15The Ohio State University, Columbus, OH
16Cancer Genetics Inc, Rutherford, NJ
17Frederick National Laboratory for Cancer Research, Frederick, MD
18Division of Cancer Epidemiology and Genetics,, National Cancer Institute, Rockville, MD
19Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD
20Leidos Biomedical Research, Inc. Frederick National Laboratory for Cancer Research, Frederick, MD
21Center for Research on Genomics & Global Health, NHGRI, Bethesda, MD
22Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD
23Center for Research on Genomics and Global Health, National Human Genome Research Institute, Bethesda, MD
24University of Malawi, Blantyre, Malawi
25University of York, York, United Kingdom
26Research Department, Ministry of Health, Lilongwe, Malawi
27Queen Elizabeth Central Hospital, Blantyre, MWI
28University of York, York, GBR
29Cancer Genomics Research Laboratory, Frederick National Laboratory, Frederick, MD
30Sickle Cell Branch, National Institutes of Health, National Heart, Lung & Blood Institute, Bethesda, MD
31Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD
32Division of Cancer Epidemiology and Genetics, National Cancer Institute, Silver Spring, MD

Antonio Frolli, MD1*, Silvia Varvello, MD2*, Annalisa Balbo Mussetto, MD3*, Daniela Gottardi, MD2*, Martina Bullo, MD1*, Silvia Marini, PhD1*, Giuseppe Saglio, MD1, Stefano Cirillo, MD3*, Daniela Cilloni, MD4* and Guido Eugenio Parvis, MD2*

1Department of Clinical and Biological Sciences, University of Turin, Turin, Italy
2Division of Hematology, Mauriziano Hospital, Turin, Italy
3Division of Radiology, AO Ordine Mauriziano, Turin, Italy
4Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy

*signifies non-member of ASH